Quest Diagnostics
DGX
DGX
661 hedge funds and large institutions have $13.1B invested in Quest Diagnostics in 2018 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 189 increasing their positions, 259 reducing their positions, and 50 closing their positions.
Holders
661
Holders Change
+9
Holders Change %
+1.38%
% of All Funds
15.15%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
65
Increased
189
Reduced
259
Closed
50
Calls
$51.7M
Puts
$42.2M
Net Calls
+$9.46M
Net Calls Change
+$10.7M
Top Buyers
| 1 |
HM
1
HealthCor Management
New York
|
$110M |
| 2 |
2
Invesco
Atlanta,
Georgia
|
$144M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$150M |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$81.8M |
| 5 |
5
Bank of New York Mellon
New York
|
$196M |
Top Sellers
| 1 |
1
AllianceBernstein
Nashville,
Tennessee
|
$55.2M |
| 2 |
2
Goldman Sachs
New York
|
$104M |
| 3 |
3
APG Asset Management
Amsterdam,
Netherlands
|
$79.1M |
| 4 |
4
BlackRock
New York
|
$1.64B |
| 5 |
5
Balyasny Asset Management
Chicago,
Illinois
|
$248K |
